Medical Biomimetics Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The medical biomimetics market size has grown strongly in recent years. It will grow from $36.6 billion in 2024 to $39.56 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increased biomimetic materials, increased research funding, aging population, rising chronic diseases.

The medical biomimetics market size is expected to see strong growth in the next few years. It will grow to $50.68 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing demand for organ transplants, growing awareness of biomimetics applications, rising healthcare expenditure, expanding biotechnology sector, advancements in tissue engineering. Major trends in the forecast period include Bio-inspired prosthetics, biomimetic sensors, synthetic biology applications, smart drug delivery systems, biologically inspired robotics, Personalized medicine, 3D printing technologies, artificial intelligence in diagnostics, nanotechnology applications, regenerative medicine.

The rising prevalence of obesity and heart disease is expected to drive the growth of the medical biomimetics market. Obesity is a condition in which excess body fat accumulates to unhealthy levels, while heart disease encompasses a variety of conditions that affect the heart and blood vessels. Biomimetics plays a crucial role in developing assistive devices, such as orthotics and prosthetics, that can help individuals with conditions like diabetes or obesity manage their health. For example, in August 2022, a report by the American College of Cardiology, a US-based non-profit medical association, projected an increase in all four major cardiovascular risk factors in the United States from 2025 to 2060. The largest rise was anticipated in diabetes, with a 39.3% increase to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). The study also indicated significant increases in cardiovascular disease rates, particularly for stroke (33.8% to 15 million), heart failure (33.4% to 13 million), ischemic heart disease (30.7% to 29 million), and heart attack (16.9% to 16 million). As a result, the growing rates of obesity and heart disease are contributing to the expansion of the medical biomimetics market.

Major companies operating in the medical biomimetics market are focused on developing innovative products with advanced technologies, such as suture anchor system to increase their profitability in market. A suture anchor system is a medical device used in orthopedic and sports medicine procedures for securing soft tissues, such as tendons or ligaments, to bone. Suture anchor systems strive to replicate and improve upon the natural attachment of soft tissues to bone, offering a functional and biomechanically optimized solution mirroring physiological tissue connections in the human body. For instance, in December 2022, Stryker Corporation, a US-based multinational medical technologies company, launches Citrefix, a disposable suture anchor system, incorporates a resorbable biomimetic anchor body using Citregen, an elastomeric material crafted from a citrate polymer, specifically engineered to emulate bone chemistry. This design allows for controlled resorption without inducing chronic inflammation. It is a disposable suture anchor system that is designed to help grafted tissue heal and healthy bone grow when used in orthopedic surgical applications.

In July 2024, Edwards Lifesciences, a US-based medical technology company, acquired Innovalve Bio Medical for $300 million. This acquisition allows Edwards to reinforce its position in the expanding market for TMVR devices, which is expected to experience significant growth in the coming years. Innovalve Bio Medical is an Israel-based provider of medical biomimetics.

Major companies operating in the medical biomimetics market are BASF SE, Bayer Aktiengesellschaft, Abbott Laboratories, Stryker Corporation, Zimmer Biomet Holdings Inc., Otsuka Medical Device Company Ltd., LivaNova PLC, Össur hf., Forschungszentrum Jülich GmbH, Biohorizons Implant Systems Inc., Inventia Plc, Blatchford Limited, Keystone Dental Corporation, Xtant Medical Holdings Inc., AVINENT Science and Technology, SynTouch Inc., Curasan Inc., CorNeat Vision Inc., Hstar Technologies Co. Ltd., Veryan Medical Ltd., Swedish Biomimetics 3000 ApS, Osteopore International Pte Ltd., KitoTech Medical Ltd., Vandstrom Inc.

North America was the largest region in the medical biomimetics market in 2024. The regions covered in the medical biomimetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical biomimetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical biomimetics market consists of sales of diagnostic tools, wound healing products, bio-inspired robotics, bioelectronic devices and regenerative medicine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Medical biomimetics refers to the development and application of innovative technologies that replicate and enhance natural physiological processes, aiming to create functional and biomechanically optimized solutions in the field of healthcare. Medical biomimetics plays a crucial role in advancing the field of artificial organs and tissues. It is extensively employed in the design of drug delivery systems that emulate biological processes, improving the precision and efficiency of targeted medication delivery.

The main types of medical biomimetics are cardiovascular, orthopedic, ophthalmology, dental, and others. Cardiovascular medical biomimetics involves the study and application of principles inspired by nature to develop innovative solutions for heart and vascular-related medical challenges. These are used in various applications such as wound healing, tissue engineering, drug delivery, and others and are used by various end-users such as hospitals, specialty clinics, and others.

The main types of medical biomimetics are cardiovascular, orthopedic, ophthalmology, dental, and others. Cardiovascular medical biomimetics involves the study and application of principles inspired by nature to develop innovative solutions for heart and vascular-related medical challenges. These are used in various applications such as wound healing, tissue engineering, drug delivery, and others and are used by various end-users such as hospitals, specialty clinics, and others.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.